High ethical standards significantly contribute to the authenticity of scientific publications, fostering public trust in scientific findings and thereby enhancing the credibility of research work or concepts.
Globalmeetx accepts only original research that has not been published previously or is currently under review for publication. The organization utilizes a verified software tool to identify similarities and overlaps in the submitted documents. Any information determined to be plagiarized from other authors' manuscripts will be promptly rejected, and authors will be required to make significant revisions as recommended by the reviewers.
A publication that significantly overlaps or is closely related to any existing article that has already been published, is currently in press, or is under review is classified as a duplicate or redundant publication. Duplicate or redundant submission refers to an identical manuscript, or one containing similar data, that is submitted to multiple journals for publication. International copyright laws, ethical standards, and the efficient use of resources are in place to guarantee the originality of submitted manuscripts.
Manuscripts must be original and must not be published or submitted to other venues while they are under review for publication with a specific publisher. As stated in the APA code of ethics (APA Publication Manual, 2010), duplicate publication constitutes a breach of publication ethics and will result in rejection.
If the author has any uncertainties regarding the reuse of a figure that has been published previously or is under copyright, it is advisable for them to consult with the editorial board members responsible for their manuscript. In these situations, the author must obtain and present documentation from the original publisher or permission from the copyright holder to allow for the figure's republication. If the author was unaware of any breach of the code and the material has already been published, appropriate steps should be taken to address the issue by submitting a revised manuscript that includes the necessary amendments to rectify the ethical violation.
Any submitted document that is discovered to include citations aimed at artificially inflating the citation count of a specific author will be regarded as an instance of citation manipulation.
If the submitted documents are found to be counterfeit or altered, particularly if the experimental results include manipulated images, this will be regarded as an act of falsification or fabrication.
All authors who are listed or referenced must have made substantial contributions to the submitted research and should endorse all claims made within it. It is essential to identify the specific individuals who contributed significantly, including students and laboratory technicians.
To ensure transparency and assist readers in making informed assessments regarding potential bias, authors are required to disclose any financial interests that may conflict with the work being presented.
At the time of submission, it is mandatory for each author to disclose any financial interests or collaborations, whether direct or indirect, that could suggest a conflict of interest or bias in the submitted work, its conclusions, opinions expressed, implications, or any other funding sources related to direct or indirect academic competition.
Furthermore, for manuscripts that have been accepted, it is essential to include a statement regarding Conflict of Interest within the document.
Obtaining permission from the copyright holder is crucial for reproducing any material. Articles cannot be published directly without securing these permissions.
It is crucial to safeguard the privacy rights of patients. Please ensure that you collect and retain copies of consent forms that explicitly reference the patients or other relevant aspects of your research. Exercise due diligence in protecting their identities when submitting documents for publication, including photographs or any materials that could potentially identify them. If consent forms have not been secured, it is imperative to either obtain them or eliminate any elements from the document that could disclose individual identities. Additionally, the acquired consent must be documented in the 'Methods' section of your manuscript. Editors may request copies of the consent forms if necessary.
All manuscripts that involve original human or animal data must include a statement regarding ethics approval at the beginning of the Methods section. Additionally, the following information should be provided: the name and address of the ethics committee responsible, the protocol number, and the date of approval granted by the aforementioned ethics committee.
For instance, the paragraph may state:
"Ethical approval for this study was granted by the Ethical Committee of [specific University or Hospital], located in [specific place], on [specific date]."
Moreover, as previously mentioned for studies involving human participants, it is essential to clearly indicate that written consent has been obtained from the participants, confirming that they have read and understood the study details and are participating voluntarily. Please refer to the most recent version of the Declaration provided by the relevant organization. In the case of experiments involving animals, it is necessary to outline the animal care and licensing guidelines under which the study was conducted and reported, in accordance with the ARRIVE guidelines (Animals in Research: Reporting In Vivo Experiments). If ethics clearance was not required or if there were any deviations from standard ethical protocols, a specific explanation must be provided. It is important to note that editors may request evidence of ethical approval. Additionally, if you have received approval from a National Drug Agency (or a similar body), please include this information and provide relevant details, as it may be particularly pertinent when discussing the use of unlicensed drugs.
